Accumulation of advanced glycation end products as a molecular mechanism for aging as a risk factor in osteoarthritis. - Wikidata - wikimedia - TriplyDB

Accumulation of advanced glycation end products as a molecular mechanism for aging as a risk factor in osteoarthritis.

Accumulation of advanced glycation end products as a molecular mechanism for aging as a risk factor in osteoarthritis.

http://www.wikidata.org/entity/Q44839345

about

Chondrocyte Apoptosis in the Pathogenesis of Osteoarthritis Pathophysiology of osteoarthritis: canonical NF-κB/IKKβ-dependent and kinase-independent effects of IKKα in cartilage degradation and chondrocyte differentiation An overview of underlying causes and animal models for the study of age-related degenerative disorders of the spine and synovial joints Animal models of osteoarthritis: classification, update, and measurement of outcomes Consequences of metabolic and oxidative modifications of cartilage tissue Why is osteoarthritis an age-related disease?Functional cartilage MRI T2 mapping: evaluating the effect of age and training on knee cartilage response to running.Signaling pathways in cartilage repair.Age-related changes in the musculoskeletal system and the development of osteoarthritis.Chondroprotective effects and mechanisms of resveratrol in advanced glycation end products-stimulated chondrocytes Advanced glycation end products induce the expression of interleukin-6 and interleukin-8 by receptor for advanced glycation end product-mediated activation of mitogen-activated protein kinases and nuclear factor-κB in human osteoarthritis chondrocyt Increased pentosidine, an advanced glycation end product, in serum and synovial fluid from patients with knee osteoarthritis and its relation with cartilage oligomeric matrix protein.Age-dependent alteration of TGF-β signalling in osteoarthritis.Extracellular localization of galectin-3 has a deleterious role in joint tissues Endoplasmic reticulum stress induces the expression of COX-2 through activation of eIF2α, p38-MAPK and NF-κB in advanced glycation end products stimulated human chondrocytes.Matrix cross-linking-mediated mechanotransduction promotes posttraumatic osteoarthritis Ligament Injury, Reconstruction and Osteoarthritis.Biomarkers associated with clinical phenotypes of hand osteoarthritis in a large multigenerational family: the CARRIAGE family study.Pentosidine, an advanced glycation end-product, may reflect clinical and morphological features of hand osteoarthritis The Actual Level of Symptomatic Soft Disc Herniation in Patients with Cervical Disc Herniation.Synovium and the innate inflammatory network in osteoarthritis progression.Potential biomarkers of ageing.Arterial stiffness and hand osteoarthritis: a novel relationship?Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix.Green tea polyphenol epigallocatechin-3-gallate inhibits advanced glycation end product-induced expression of tumor necrosis factor-alpha and matrix metalloproteinase-13 in human chondrocytes.Protein oxidation, nitration and glycation biomarkers for early-stage diagnosis of osteoarthritis of the knee and typing and progression of arthritic disease.Maslinic acid in olive fruit alleviates mild knee joint pain and improves quality of life by promoting weight loss in the elderly.Advanced glycation end products induce cell cycle arrest and proinflammatory changes in osteoarthritic fibroblast-like synovial cells Sex differences in the association of skin advanced glycation endproducts with knee osteoarthritis progression.NF-kappaB signaling: multiple angles to target OA.Microsomal prostaglandin e synthase-1 in rheumatic diseases.Intervertebral disc degeneration: evidence for two distinct phenotypes.Impact of diabetes and its treatments on skeletal diseases.The Maillard reaction and pet food processing: effects on nutritive value and pet health.Why do some intervertebral discs degenerate, when others (in the same spine) do not?Effects of advanced glycation end products on the expression of COX-2, PGE2 and NO in human osteoarthritic chondrocytes.Advanced glycation end products increases matrix metalloproteinase-1, -3, and -13, and TNF-alpha in human osteoarthritic chondrocytes.Effects of a joint supplement whose main components are resveratrol and hyaluronic acid on some biochemical parameters in aged lame horses.Molecular and intermolecular effects in collagen fibril mechanics: a multiscale analytical model compared with atomistic and experimental studies.Pro-inflammatory effects of early non-enzymatic glycated proteins in human mesothelial cells vary with cell donor's age.

P2860

Q26777068-7724D642-16B5-4C82-811D-306FE4AED92B Q26777901-D2EB156F-049A-4F94-8D3F-2A285F41B4F7 Q26828043-8D167935-DF44-457D-A20F-308F4A88D966 Q28072990-8E5DB1C8-6936-4193-8009-2AED14355991 Q28085716-2FC97D38-DDD8-4B9E-A61E-0F04EFFF024D Q33636855-3BCEE458-62C2-49C6-AD48-61E62FFD0F3D Q33679148-DE2E1D6F-407E-4003-A732-BA38AEB9CDDC Q33755839-FBDDF47D-0533-42F8-B18B-7D38A69EC4B9 Q34062933-619E830D-8CA4-4A6D-B850-4103BC7B9FC1 Q34346185-62EC8EC9-E7E3-492F-ADA1-8B8CFA187E0C Q34802374-1263D378-DD9B-4620-984D-2EEBF7090B1C Q35555571-C13A56C2-DF26-4EC6-A975-842068D37EAE Q35649296-08525D24-D274-4094-A827-4C2065A7819A Q35769105-21712B4D-1709-4C12-8BF4-672CAE16D635 Q35875201-407A30A5-05AF-46D9-8FE2-38683CD0AEA6 Q35910195-38250277-5373-4EFE-88F4-FC84569E39EF Q35941025-9C536000-3FCA-4025-A9A4-F2C9A0BC7085 Q35973947-87192939-E10F-4FAE-A4B6-4D4D9B9E9074 Q36041246-924C0A06-01B1-4E11-B4F7-AA4674F8CF36 Q36215182-5044DF4E-3C8F-409E-A77E-4D32D63D3176 Q36813665-E3B38C24-C7DC-42DD-8828-4F90FE11290D Q37061417-20C3F6D8-1290-47A7-B0E6-65286D5ECEB3 Q37104274-0F625B6C-7AB8-46D1-B6F4-84F1B95BC416 Q37268683-A1A3C7D6-E600-4F1F-949F-59736D49ADBC Q37270775-32E4B6CD-EB4A-45C3-A442-DF24D45C591C Q37369591-2C2BA5DD-B0D0-4022-A9B6-B5EC3DD4C516 Q37416570-1B7F9D71-5FA9-4F52-9E81-A00E8A4A66ED Q37454060-5CD67082-57B0-47B4-ABD5-C8664EDCC1AC Q37651032-C19FDB77-77BD-4593-A119-34D278C3F2E9 Q37701897-DF5A6A94-C296-4C58-A113-172055921CB6 Q37934565-58C4B123-16BE-4165-9EFC-947C582163AB Q38033602-0DAEEDEA-193A-4ECB-857D-18B0E86BDBA9 Q38078839-AC58CC22-1D6F-4467-BFDB-075589A5D4DE Q38126643-56419F16-6011-42EE-A147-617E69587C64 Q38206184-000A75D5-6B49-45BD-B65B-99A9C097C0D3 Q38502228-836B1845-9B64-47AB-8FD7-D8DC99BB388B Q38506314-818457A3-E67F-4B30-A2EA-D54C68CC4E5C Q40052894-70CD9599-09D8-43B6-824E-9144BB9EABDA Q40684510-3B24064B-93AE-49AF-8CFA-247E583F0193 Q41603094-F3018FC7-C9ED-42D3-A8EB-97909FF589B8

P2860

Accumulation of advanced glycation end products as a molecular mechanism for aging as a risk factor in osteoarthritis.

http://www.wikidata.org/entity/Q44839345

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Accumulation of advanced glyca ...... risk factor in osteoarthritis.

@en

Accumulation of advanced glyca ...... risk factor in osteoarthritis.

@nl

type

label

Accumulation of advanced glyca ...... risk factor in osteoarthritis.

@en

Accumulation of advanced glyca ...... risk factor in osteoarthritis.

@nl

prefLabel

Accumulation of advanced glyca ...... risk factor in osteoarthritis.

@en

Accumulation of advanced glyca ...... risk factor in osteoarthritis.

@nl

P1433

Q44839345-F1E81735-0CCB-48E1-8A8E-566A5A984993

P1476

Q44839345-82BDE216-AF73-462A-A7A4-DB603DC4F32B

P2093

Q44839345-0FBB717A-86E8-402F-9FE9-9D2384C71FCA

Q44839345-2374F847-2416-401A-BD96-F2F2CCCA21CB

Q44839345-2D65EBD8-18A7-42A1-8FBD-675B86FDB1FB

Q44839345-4F0C520C-8648-473B-BAA1-429DC9D53B45

Q44839345-AEA19CC0-D95D-4D26-8BFA-81A182389871

Q44839345-CDA0F6DA-3B82-4056-B02D-23ABF039BA50

Q44839345-D5705B00-1F7A-4504-BBB0-D0FDDEC9A9FA

Q44839345-D888F821-3033-498F-AAE1-7D11DFAFB6E5

Q44839345-E866E7A3-0E97-41B4-A810-EEB436C60181

Q44839345-F4FE6521-34C9-4504-A60A-435A8C80F8AE

P2860

Q44839345-5A3901EB-5A9A-4C22-9F06-1B8F8A69F0E2

Q44839345-7A835A15-5C80-47FB-A19D-A29A10AC0586

Q44839345-AE4CDDAD-1442-425A-B9BD-1E4FE629AEF1

Q44839345-CE2AE234-B3B0-412D-832C-210EF7377BC5

Q44839345-FD742DBC-857D-4F29-9605-D1D91FBF5EDE

P304

Q44839345-0EC86814-F5C1-4DA8-AA44-5328DE251F74

P31

Q44839345-D8DB061C-F75F-4966-AC04-93801BA4A8B0

P356

Q44839345-8D33B618-5F25-41F3-B77B-5080022C7F23

P433

Q44839345-FA348A87-B644-452F-A9F1-FCEC12E7A5C0

P478

Q44839345-23F9799F-7DDD-45DE-B939-43CE66D49B60

P577

Q44839345-72AF641C-294F-4C27-8438-14E7A5C7B87A

P5875

Q44839345-87BAA425-95D4-4839-9971-519E781CAB37

P698

Q44839345-F04C3A2C-CC1A-4251-BB9C-CC5D9B44B20B

P921

Q44839345-909411FD-969A-43F9-B2E0-BBD5E6EAAA23

Q44839345-F351BC14-1F91-4863-8129-2BF3A284B464

P356

P1433

Arthritis & Rheumatology

P1476

Accumulation of advanced glyca ...... risk factor in osteoarthritis.

@en

P2093

Benno Van El

http://www.w3.org/2001/XMLSchema#string

Floris P J G Lafeber

http://www.w3.org/2001/XMLSchema#string

Jeroen DeGroot

http://www.w3.org/2001/XMLSchema#string

Johan M TeKoppele

http://www.w3.org/2001/XMLSchema#string

Johannes W J Bijlsma

http://www.w3.org/2001/XMLSchema#string

Kim M G Jacobs

http://www.w3.org/2001/XMLSchema#string

Marion J G Wenting-van Wijk

http://www.w3.org/2001/XMLSchema#string

Nicole Verzijl

http://www.w3.org/2001/XMLSchema#string

Peter M Van Roermund

http://www.w3.org/2001/XMLSchema#string

Ruud A Bank

http://www.w3.org/2001/XMLSchema#string

P2860

Osteoarthritis: new insights. Part 1: the disease and its risk factors.

Nonenzymatic glycation of collagen in aging and diabetes.

Chemistry of collagen cross-links: glucose-mediated covalent cross-linking of type-IV collagen in lens capsules.

Ageing and zonal variation in post-translational modification of collagen in normal human articular cartilage. The age-related increase in non-enzymatic glycation affects biomechanical properties of cartilage.

L-arginine reduces heart collagen accumulation in the diabetic db/db mouse

P304

1207-1215

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ART.20170

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P577

2004-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8625668

http://www.w3.org/2001/XMLSchema#string

P698

15077303

http://www.w3.org/2001/XMLSchema#string

P921